HOME >> MEDICINE >> NEWS
CellCept associated with reduced incidence of cancer, compared to AZA, following heart transplant

San Francisco, April 23, 2004 - A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCept (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens. Presented at the annual meeting of the International Society for Heart and Lung Transplantation (ISHLT), the study found a 27% lower risk of cancer in CellCept-treated patients. Patients studied were part of the ISHLT Transplant Registry. "Though not derived from randomized controlled trials, these data indicate that the choice of maintenance immunosuppressive regimen may be a modifiable risk factor for the development of malignancy in heart transplant recipients," said James O'Neill, M.D., Fellow in Heart Failure and Cardiac Transplantation, Cleveland Clinic.

Previous research had shown that organ transplant recipients receiving immunosuppressive therapy are three to four times more likely to develop tumors than the general population and have an even greater risk of developing certain rare cancers.

Extensive Examination of Registry Validates CellCept Treatment
The study, Mycophenolate Mofetil and the Risk of Developing Malignancy Following Orthotopic Heart Transplantation (OHT), examined competing risk factors to determine which are associated with malignancy following OHT, and was based on 3,895 patients in the ISHLT Transplant Registry. The study examined survival without malignancy in patients taking standard immunosuppressive regimens (defined as cyclosporine or tacrolimus and azathioprine or CellCept), who underwent OHT between January 1, 1995, and December 31, 1997.

Of these patients, 703 (18%) developed malignancy during the follow-up period through June 30, 2002. The breakdown of malignancy was as follows: skin (47%), post-transplant lymphoproliferative disease (10%),
'"/>

Contact: Julip Cantre
Julio.Cantre@ketchum.com
917-204-0599
Ketchum
23-Apr-2004


Page: 1 2 3

Related medicine news :

1. New data supports CellCepts position as a world leader in solid organ transplantation
2. CellCept(R) registry data demonstrated superior long-term organ transplant outcomes
3. CellCepts cardioprotective profile reinforced
4. Data shows life of kidney transplant lengthened by CellCept
5. Organizational traits associated with quality patient care are essential to home care nursing
6. Depression may explain higher risk of heart attack associated with antidepressants
7. Current daily smoking may be associated with increased risk for suicidal thoughts and attempts
8. Inpatient smoking cessation counseling is associated with early differences in mortality
9. Hypothyroidism associated with reduced breast cancer risk
10. COX-2 inhibitors associated with blood pressure elevation
11. Mothers depression associated with increased risk of childs antisocial behavior

Post Your Comments:
(Date:8/27/2014)... 27, 2014 Reviewing the prices that ... be easier for the public when using the Quotes ... promoted in all 50 states in the U.S. are ... different insurers that are generating the rates information from ... adults to use the programmed system without charge. Because ...
(Date:8/27/2014)... Los Angeles, CA (PRWEB) August 27, 2014 ... used to require a consumer to present personal information ... is changing the way that life insurance quotes are ... . , The term plans that an adult ... are provided by known U.S. companies. The system for ...
(Date:8/27/2014)... Tampa, FL (PRWEB) August 27, 2014 ... on September 5th, 6th and 7th at the Florida ... Action Festival celebrates all Latino art and cultures from ... to present their platinum sponsor Go Smart Mobile and ... in Action Festival is expecting an estimate of 4,000 ...
(Date:8/27/2014)... WEDNESDAY, Aug. 27, 2014 (HealthDay News) -- Young adults ... "hyper-connected" networks in their brain, researchers are reporting. ... lead to new ways to predict, prevent and treat ... Chicago researchers. The researchers conducted brain scans on ... in their teen years, and a control group of ...
(Date:8/27/2014)... a key role in inflaming blood vessels and hardening ... at UCLA demonstrates that they may also contribute to ... small blood vessels in the lungs. , Using a ... part of the main protein in high-density lipoprotein (HDL), ... of oxidized lipids in pulmonary hypertension. They also found ...
Breaking Medicine News(10 mins):Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Life Insurance Quotes for Term Policies Now Found at Insurer Website Online 2Health News:Marc Anthony to Perform at "Nieves Productions" Latinos in Action Festival 2Health News:Study: Young Adults Who Had Depression Have 'Hyper-Connected' Brain Networks 2Health News:Protein in 'good cholesterol' may be a key to treating pulmonary hypertension 2
(Date:8/27/2014)... Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical ... needs in oncology, autoimmune and inflammatory disease, today announced the ... be held at The New York Palace Hotel in ... Alan Fuhrman , Ambit,s CFO, will provide ... quizartinib, at 1:10 p.m. ET on Wednesday, September 3, 2014.  ...
(Date:8/27/2014)... Aug. 27, 2014  After the February 2014 launch ... billing solution for medical practices and management companies, ... the new software. "The feedback has been ... . "The sheer number of demos and new sign-ups ... was for these types of software features." ...
(Date:8/27/2014)... WARSAW, Ind. , Aug. 27, 2014  Zimmer ... in musculoskeletal care, announced that it will be participating ... the Grand Hyatt in New York, New ... David Dvorak , President and CEO of Zimmer, will ... Binder , President and CEO of Biomet, will join ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
Cached News: